Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06780436 · ClinicalTrials.gov registry record

3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) Instrument for Point-of-Care Diagnosis of Intracranial Hemorrhages

A clinical trial of Traumatic Brain Injury and Intracranial Hemorrhages, sponsored by The Geneva Foundation.

Active
Registry status
20
Enrollment target
1
Study location

NCT06780436: Active study of Traumatic Brain Injury and Intracranial Hemorrhages, sponsored by The Geneva Foundation.

NCT06780436 is a study of Traumatic Brain Injury and Intracranial Hemorrhages that is active but no longer recruiting, run by The Geneva Foundation. The registered enrollment target is 20 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06780436, a study of Traumatic Brain Injury and Intracranial Hemorrhages, is active but no longer recruiting, sponsored by The Geneva Foundation.

ACTIVE NOT RECRUITING
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to assess the safety of the 3D Transcranial Ultrasound Brain Imaging (3D TRUBI) device in Traumatic Brain Injury (TBI) patients with intracranial hemorrhage (ICH). The secondary objective is to assess the diagnostic potential of 3D TRUBI. The latter will be achieved by comparison of 3D TRUBI scans with admission head computed tomography (CT), the standard of care diagnostic modality. Demonstrating the feasibility and safety of the 3D TRUBI system is the first step toward expanding access of an alternative to CT for diagnostic imaging and triage of mass casualties of war or natural disasters in the field and in rapidly deployed medical centers or other austere environments.

Primary Outcome

The primary outcome is the assessment of the feasibility of 3D-TRUBI for the detection of ICH and other traumatic brain lesions as compared to admission head CT. This is a binary parameter for each type of lesion per patient.

Conditions Studied

Traumatic Brain Injury Intracranial Hemorrhages Traumatic Brain Hemorrhage Ultrasound Exams 3D Sonography

Interventions

  • DEVICE 3D Transcranial Ultrasound Brain Imaging

Study Locations (1)

Texas

  • Brooke Army Medical Center - Fort Sam Houston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-12-04
Est. Completion 2026-09
The Geneva Foundation

11 total trials

What the registry record for NCT06780436 still lists

NCT06780436 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower).

The record links to 5 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which 3D Transcranial Ultrasound Brain Imaging is the first listed.

NCT06780436 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06780436 about?

NCT06780436 is a clinical study titled "3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) Instrument for Point-of-Care Diagnosis of Intracranial Hemorrhages". The primary objective of this study is to assess the safety of the 3D Transcranial Ultrasound Brain Imaging (3D TRUBI) device in Traumatic Brain Injury (TBI) patients with intracranial hemorrhage (ICH). The secondary objective is to assess the diagnostic potential of 3D TRUBI. The latter will be ach...

What is the current status of trial NCT06780436?

This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2024-12-04. Estimated completion is 2026-09.

What conditions does trial NCT06780436 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Intracranial Hemorrhages, Traumatic Brain Hemorrhage, Ultrasound Exams, 3D Sonography.

What interventions are being tested in trial NCT06780436?

The interventions under investigation include: 3D Transcranial Ultrasound Brain Imaging (DEVICE).

Who is sponsoring clinical trial NCT06780436?

This trial is sponsored by The Geneva Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06780436 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06780436's enrollment target sits among peer trials

20 149th of 171 higher than 21 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06780436, the US trial registry maintained by the National Library of Medicine. NCT06780436 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.